We compared the OS in patients with m-GBM and an isolated TERTp mutation (disregarding any additional molecular aberrations that do not contribute to the diagnosis of m-GBM) with those with a TERTp mutation and additional amplification of EGFR and/or +7/−10. The gene discussed is EGFR; the disease is glioblastoma.